Rising Incidence Of Childhood Growth Hormone Deficiency Spurs Global Biosimilar Growth Hormone Market Driver: Leading Transformation in the Biosimilar Growth Hormones Market in 2025

What Are the Projected Growth and Market Size Trends for the Biosimilar Growth Hormones Market?
In the past few years, the market size of biosimilar growth hormones has significantly expanded. The market which was valued at $0.76 billion in 2024, is projected to reach $0.82 billion in 2025, representing a compound annual growth rate (CAGR) of 8.4%. Factors such as the growing demand for growth hormones, patent expirations, clinical evidence and the escalation of clinical trials have contributed to the historical growth of this market.

The market size of biosimilar growth hormones is projected to witness substantial expansion in the near future. The market is anticipated to reach $1.19 billion in 2029, with a compound annual growth rate (CAGR) of 9.8%. The growth during the forecast period can be attributed to factors such as pediatric growth disorders, broadening indications, greater detection rates, and heightened awareness of biosimilar alternatives. Noteworthy trends for the forecasted duration include a focus on pediatric biosimilars, combinations of biosimilars, ease of dosing, and repeated emphasis on combinations and convenience in dosing.

What Is Driving the Growth Trajectory of the Biosimilar Growth Hormones Market?
The rise in the rate of children dealing with growth hormone deficiency is propelling the expansion of the global biosimilar growth hormone industry. The lack of growth hormones is often a result of damage to the pituitary gland or the hypothalamus as a result of either a congenital abnormal formation or an issue that arose during or after birth (acquired). For example, Hormones Australia by the Endocrine Society of Australia (ESA), a national Australian authority on endocrine-related diseases and conditions, reported in September 2023 that growth hormone deficiency affects approximately 2 to 3 out of every 10,000 individuals. Consequently, the upsurge in the count of children with growth deficiencies is instrumental in fueling the development of the biosimilar growth hormones sector.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

Which Leading Companies Are Shaping the Growth of the Biosimilar Growth Hormones Market?
Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

What Are the Major Trends Shaping the Biosimilar Growth Hormones Market?
Leading firms in the biosimilar growth hormone sector are driving innovation through solutions such as human growth hormone to boost treatment effectiveness and affordability for those with growth hormone deficiencies. Human growth hormone solutions pertain to medical interventions or supplements aiming to stimulate or replace human growth hormone in the body, catering to growth deficiencies or anti-aging objectives. For instance, Pfizer Inc., a pharmaceutical firm based in the US, in conjunction with OPKO Health Inc., another US healthcare company, obtained approval for NGENLA (somatrogon-ghla) from the US Food and Drug Administration (FDA) in June 2023. This injectable human growth hormone treatment, which is used once a week, has been crafted for pediatric patients suffering from growth hormone deficiency (GHD). This novel long-acting growth hormone therapy serves as an alternative to daily injections and enhances adherence and convenience for patients and their caregivers. Its approval was granted based on various clinical trials that validated its effectiveness and safety, symbolizing a critical progression in growth hormone therapies.

What Are the Key Segments of the Biosimilar Growth Hormones Market?
The biosimilar growth hormones market covered in this report is segmented -

1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

Subsegments:
1) By Intravenous: Hospital-based Administration, Outpatient Clinics
2) By Subcutaneous: Self-administration, Professional Administration
3) By Intramuscular: Pediatric Care, Adult Care
4) By Oral: Tablets, Capsules

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Which Region Dominates the Biosimilar Growth Hormones Market?
The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Biosimilar Growth Hormones Global Market Report?

- Market Size Analysis: Analyze the Biosimilar Growth Hormones Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Biosimilar Growth Hormones Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Biosimilar Growth Hormones Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Biosimilar Growth Hormones Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3391

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.